The Virus Project
    Facebook Twitter Instagram
    The Virus Project
    • Home
    • Invest in Schools Summit
      • Summary
      • Strategy
      • Agenda
      • Speakers
      • White Papers
      • Register
      • Purchase Tickets
      • COVID Safety
      • Venues  
      • Live Streaming
    • Events
      • Back to School Conference
        • Videos
        • Summary
        • Sponsors
        • Agenda
        • Speakers
      • The Contagion Conference
    • Initiatives
      • Overview
      • University Research Network
      • Impact Investment Network
    • Approaches
      • Testing
      • Containment
      • Therapies
      • Vaccines
    • Resources
      • Research Library
      • COVID Tests Research Report
      • Marketplace
      • Organizations
      • Media Resources
    • About
      • THE VIRUS PROJECT
      • About the Site
      • Virus Project Team
      • Altru Institute
      • Newsletters
      • Open Source Journalism
      • Join
        • Back to School Conference Registration
        • Join to BEAT COVID
        • Invest
    • Log In
    The Virus Project
    You are at:Home»Therapeutics»Category: "Therapy Tech"

    Browsing: Therapy Tech

    275-Person Antibody Treatment Study Reports 5-Day Reduction in Symptoms

    0
    By VP Staff on September 30, 2020 NEWS, Therapeutics, Therapy Tech

    Regeneron Pharmaceuticals, Inc. announced last week that its experimental two-antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients. The treatment, REGN-COV2, is also being studied for use in hospitalized patients, and for prevention of infection in people who have been exposed to COVID-19.  The FDA can authorize emergency use of a drug before completing its review for a formal approval. Analysts believe that the Regeneron cocktail could work in a hospital setting where the patient is already severely ill and has a high viral load. Trial results for the first 275 patients showed the biggest effect in…

    Read More

    A Treatment to Crush COVID? “Medicinal Signaling Cells” Found Throughout the Body can Eliminate The Virus.

    0
    By VP Staff on August 16, 2020 NEWS, The Sentinel, Therapeutics, Therapy Tech

    Opinion in the Wall Street Journal describes a Covid-19 therapy using “medicinal signaling cells,” or MSCs, which are found on blood vessels throughout the body. These cells eliminate the virus, calm the immune overreaction known as a cytokine storm, and repair damaged lung tissue. According to the author who is a co-founder of a company in this space, this combination is offered by no other drug, making this a regenerative medicine that could be as revolutionary as Jonas Salk’s polio vaccine. NOTE: Share price of Osiris  (the company developing this technology) rose dramatically after this article appeared, moving from .03…

    Read More

    Common FDA-Approved Drug Heparin May Neutralize COVID-19

    0
    By VP Staff on July 21, 2020 NEWS, Therapeutics, Therapy Tech

    A common drug, already approved by the FDA, may also be a powerful tool in fighting COVID-19, according to research published this week. Heparin could be used as a decoy to prevent SARS-CoV-2 from infecting human cells. SARS-CoV-2, the virus that causes COVID-19, uses a surface spike protein to latch onto human cells and initiate infection. But heparin, a blood thinner also available in non-anticoagulant varieties, binds tightly with the surface spike protein, potentially blocking the infection from happening. This makes it a decoy, which might be introduced into the body using a nasal spray or nebulizer and run interference…

    Read More
    VIRUS PROJECT UPDATES
    September 13, 2021

    New Approach to K-12 Education. Self-Directed Model to Present at Altru Salon

    June 9, 2021

    Altru Virus Project Summit in DC to Focus on Stronger Schools

    June 8, 2021

    Core Curriculum for Invest in Schools Summit

    January 26, 2021

    How to Reopen Schools and Keep Them Open. A Virus Project White Paper

    September 1, 2020

    University Fellowships. A Global Network of Scientists to Address Big Challenges like COVID

    About

    The global communications platform for those collaborating to beat the Coronavirus.
    INITIATIVES
    • Invest in Schools Summit
    • University Research Consortium
    • Impact Investment Network
    Links

    Editorial Approach

    Submit Stories/Projects

    Contact Us

    Account Login

    Copyright © 2020

    Type above and press Enter to search. Press Esc to cancel.